Integrated Neuromuscular Inhibition Versus Instrument Assisted Soft Tissue Mobilization in Chronic Back Pain

Chronic Non Specific Low Back Pain Clinical Trial

Official title:

Integrated Neuromuscular Inhibition Technique Versus Instrument Assisted Soft Tissue Mobilization in Patients With Chronic Non Specific Low Back Pain

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06116058
• Other study ID #: P.T.REC/012/004714
• Status: Not yet recruiting
• Phase: N/A
• Start date: November 1, 2023
• Est. completion date: March 1, 2024

Study information

• Verified date: October 2023
• Source: Cairo University
• Contact: Heba S mousa, master
• Phone: 01128524303
• Email: salamaheba734[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

this study will be conducted to identify the difference between the effect of integrated neuromuscular inhibition technique and instrument assisted soft tissue mobilization on back pain, pain threshold, back rang of motion ,back proprioception and back disability in chronic non specific low back pain

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 45
• Est. completion date: March 1, 2024
• Est. primary completion date: March 1, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• 1. The patient's age ranged from 18 to 30 years.(Geogre et al, 2021) 2. Patients with low back pain for more than 3 months (pain felt between T12 and the gluteal fold).

3. Patient with chronic low back pain 4. Normal body mass index from 18 -25kg/m2.

Exclusion Criteria:

• The subjects will be excluded if they have any of the followings:

1. Lumbar discogenic lesions or any inflammatory arthritis, tumors, infection involving the lumbar spine.

2. Patients with decreased range of motion secondary to congenital anomalies, muscular contracture, or bony block.

3. Previous lumbar or hip surgery or trauma.

4. Any hip structural abnormality such as malformations, impingements and degeneration.

5. Patients With cognitive impairments that would limit their participation

Related Conditions & MeSH terms

• Back Pain
• Chronic Non Specific Low Back Pain
• Low Back Pain

Intervention

Other:
• Experimental: Group A: integrated neuromuscular inhibition technique
will receive integrated neuromuscular inhibition in addition to conventional treatment,INIT which included IC, SCS, and MET for the low back region for the quadratus lumborum( QL) and erector spinae (ES) muscles
• Experimental: Group B :Instrument assissted soft tissue mobilization
IASTM performed on lumbar posterior muscle erector spinae (iliocostalis, longissimus), and quadratus lumborum(QL) The IASTM treatment was applied for approximately 20-seconds in a direction parallel to the muscle fibers being treated with the instrument at a 45° angle. Followed immediately by treating the muscles in a direction perpendicular to the muscle fibers with the instrument at a 45° angle for an additional 20-seconds, resulting in a total treatment time of approximately 40 seconds.
• control group C conventional physical therapy
. The control group will applied general exercise. General exercise were applied with stretching exercises and stationary bicycling for 10-15 minutes14, 15) . Three sets of fifteen repetitions will performed, with rest times of 1 minute between sets during 4 weeks.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change in lumber proprioception	change in lumbar proprioception will be measured by dual inclinometer for 3 group pre-and post-treatment	Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure
Primary	chang in pain pressure threshold	change in lower back pain threshold will be measured by pressure algometer for 3 group pre-and post-treatment	Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure
Secondary	chang in lumbar rang of motion(ROM)	lumbar ROM will be measured by dual inclinometer pre-treatment and post treatment	Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure
Secondary	functional disability oFlumbar spine	functional disability will be measured by The Arabic version of Oswestry Disability Index.(ODI)	Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure
Secondary	pain level of lumbar spine	pain level will be measured by visual analoge scale(VAS)	Evaluation will be performed priod to the first treatment session :as a baseline measure,and at least treatment session (after 4 weeks)as a post-treatment measure